Cervical Length Measurement Timing for Preterm Birth
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It focuses on measuring cervical length during pregnancy and does not mention any medication restrictions.
What data supports the effectiveness of the treatment Cervical Length Measurement for preterm birth?
Is cervical length measurement safe for humans?
How is cervical length measurement different from other treatments for preventing preterm birth?
Cervical length measurement is unique because it involves using ultrasound to measure the length of the cervix during pregnancy to predict the risk of preterm birth, rather than using medication or physical interventions. This approach focuses on early detection and monitoring rather than direct treatment.12101112
What is the purpose of this trial?
The goal of this clinical trial is to determine the optimal timing for measuring cervical length (CL) during fetal anatomy surveys in pregnant individuals. This study focuses on improving the accuracy of cervical length assessments, which are critical for identifying individuals at risk for preterm birth. The main questions it aims to answer are:* Does measuring cervical length at the beginning of the anatomy survey result in a higher proportion of scans meeting the nine CLEAR (Cervical Length Education and Review) criteria compared to measuring at the end of the survey?* Does the use of sepia-filtered ultrasound images improve the proportion of scans meeting the nine CLEAR criteria compared to conventional grayscale images?Researchers will compare two groups of participants randomized to have cervical length measured either at the beginning or at the end of the anatomy survey. Additionally, all participants will undergo cervical length measurements using both grayscale and sepia-filtered ultrasound imaging.Participants will:* Receive a patient information sheet through MyChart explaining the study and standard cervical length screening during anatomy surveys.* Provide verbal consent for a transvaginal ultrasound and study participation.* Be randomized to have their cervical length measured at either the start or end of the fetal survey.* Undergo cervical length measurement using both grayscale and sepia-filtered ultrasound imaging modalities.* This study involves no additional risks beyond those of routine clinical care and aims to enhance clinical practice by identifying optimal methods for cervical length assessment during pregnancy.
Research Team
Raminder Khangura, MD
Principal Investigator
Henry Ford Health
Eligibility Criteria
This trial is for pregnant individuals undergoing routine fetal anatomy surveys. It's designed to find the best time to measure cervical length, which helps predict preterm birth risk. Participants must consent to a transvaginal ultrasound and be okay with being randomly assigned when their cervical length will be measured.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Randomization and Intervention
Participants are randomized to have cervical length measured at either the start or end of the anatomy survey using both grayscale and sepia-filtered ultrasound imaging.
Data Collection and Analysis
Cervical length measurements are collected and analyzed for adherence to the nine CLEAR criteria.
Follow-up
Participants are monitored for any adverse effects and the study outcomes are evaluated.
Treatment Details
Interventions
- Cervical Length Measurement
Find a Clinic Near You
Who Is Running the Clinical Trial?
Henry Ford Health System
Lead Sponsor